Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP4K4 | O95819 | 5/20 | 0.68 |
| ▸ | NOS3 | P29474 | 1/20 | 0.50 |
| ▸ | NOS2 | P35228 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.49 |
| ▸ | PIK3CD | O00329 | 3/20 | 0.48 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.46 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.46 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.43 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.43 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30254720 | 0.82 | MAP4K4 (0.58) | MAP4K4NOS3NOS2PIK3CDDYRK1A | |
| SCHEMBL4404645 | 0.81 | HSD17B1 (0.55) | MAP4K4RAB9AENPP3 | |
| SCHEMBL17027804 | 0.81 | MAP4K4 (0.72) | MAP4K4PIK3CDDYRK1ADYRK1BMKNK1 | |
| SCHEMBL2757248 | 0.81 | MAP4K4 (0.46) | MAP4K4RAB9APIK3CDPIK3CGENPP3 | |
| SCHEMBL13040 | 0.81 | MAP4K4 (0.66) | MAP4K4RAB9AADORA1ALDH1A1NPC1 | |
| SCHEMBL1477226 | 0.79 | MAP4K4 (0.70) | MAP4K4PIK3CDDYRK1ADYRK1BMEN1 | |
| SCHEMBL21995625 | 0.78 | MEN1 (0.68) | MAP4K4NOS3NOS2RAB9APIK3CD | |
| SCHEMBL12864338 | 0.78 | NOS3 (0.67) | MAP4K4NOS3NOS2PIK3CDALDH1A1 | |
| SCHEMBL13680468 | 0.78 | GRIN1 (0.53) | MAP4K4RAB9ANPC1TP53SMN1; SMN2 | |
| SCHEMBL11158811 | 0.78 | CYP2A6 (0.55) | MAP4K4RAB9APIK3CDNPC1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3561892-B1 | ORGANIC LIGHT-EMITTING DEVICE | LT MATERIALS CO LTD (KR) | 2023-05-10 | — | — | EP | disclosed |
| US-11434245-B2 | WNT pathway modulators | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2022-09-06 | — | — | US | disclosed |
| US-11434245-B2 | WNT pathway modulators | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2022-09-06 | — | — | US | disclosed |
| WO-2021130638-A1 | DIACYLGLYCEROL KINASE MODULATING COMPOUNDS | CARNA BIOSCIENCES, INC. (JP) | 2021-07-01 | — | — | WO | disclosed |
| US-20210047336-A1 | WNT PATHWAY MODULATORS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2021-02-18 | — | — | US | disclosed |
| US-20210047336-A1 | WNT PATHWAY MODULATORS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2021-02-18 | — | — | US | disclosed |
| US-10870653-B2 | WNT pathway modulators | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2020-12-22 | — | — | US | disclosed |
| US-10870653-B2 | WNT pathway modulators | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2020-12-22 | — | — | US | disclosed |
| EP-3561892-A1 | ORGANIC LIGHT-EMITTING DEVICE | Heesung Material Ltd. (KR) | 2019-10-30 | — | — | EP | disclosed |
| US-20190185478-A1 | WNT PATHWAY MODULATORS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2019-06-20 | — | — | US | disclosed |
| US-20160311829-A1 | WNT PATHWAY MODULATORS | AGENCY FOR SCIENCE, TECHNOLGY AND RESEARCH (SG) | 2016-10-27 | — | — | US | disclosed |
| US-20160311829-A1 | WNT PATHWAY MODULATORS | AGENCY FOR SCIENCE, TECHNOLGY AND RESEARCH (SG) | 2016-10-27 | — | — | US | disclosed |
| US-20160311829-A1 | WNT PATHWAY MODULATORS | AGENCY FOR SCIENCE, TECHNOLGY AND RESEARCH (SG) | 2016-10-27 | — | — | US | disclosed |
| EP-3083631-A1 | WNT PATHWAY MODULATORS | Agency For Science, Technology And Research (SG) | 2016-10-26 | — | — | EP | disclosed |
| WO-2015094119-A1 | WNT PATHWAY MODULATORS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2015-06-25 | — | — | WO | disclosed |
| WO-2015094119-A1 | WNT PATHWAY MODULATORS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2015-06-25 | — | — | WO | disclosed |
| WO-2013078320-A1 | MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF | CONSTELLATION PHARMACEUTICALS (US) | 2013-05-30 | — | — | WO | disclosed |
| WO-2011097300-A1 | PHENYLALANINE DERIVATIVES AND THEIR USE AS NON-PEPTIDE GLP-1 RECEPTOR MODULATORS | ARGUSINA, INC. (US) | 2011-08-11 | — | — | WO | disclosed |
| US-7645799-B2 | Substituted biaryl compounds as factor XIa inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2010-01-12 | — | — | US | disclosed |
| US-20090062287-A1 | SUBSTITUTED BIARYL COMPOUNDS AS FACTOR XIA INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2009-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160311829-A1 | WNT PATHWAY MODULATORS | WNT1, WNT3A, WNT3 | MAP4K4 742/4885NOS3 3569/4885NOS2 3778/4885 |
| US-20190185478-A1 | WNT PATHWAY MODULATORS | WNT1, WNT3A, WNT3 | MAP4K4 2438/4885NOS3 3032/4885NOS2 4112/4885 |
| US-11434245-B2 | WNT pathway modulators | WNT1, WNT3A, WNT3 | MAP4K4 437/4885NOS3 4474/4885NOS2 4663/4885 |
| US-10870653-B2 | WNT pathway modulators | WNT1, WNT3A, WNT3 | MAP4K4 914/4885NOS3 3822/4885NOS2 4529/4885 |
| US-20090062287-A1 | SUBSTITUTED BIARYL COMPOUNDS AS FACTOR XIA INHIBITORS | TFPI, F3, F12 | MAP4K4 368/4885NOS3 2254/4885NOS2 4313/4885 |
| US-20210047336-A1 | WNT PATHWAY MODULATORS | WNT1, WNT3A, WNT3 | MAP4K4 2438/4885NOS3 3032/4885NOS2 4112/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.